Cargando…
Barriers impeding serologic screening for celiac disease in clinically high-prevalence populations
BACKGROUND: Celiac disease is present in ~1% of the general population in the United States and Europe. Despite the availability of inexpensive serologic screening tests, ~85% of individuals with celiac disease remain undiagnosed and there is an average delay in diagnosis of symptomatic individuals...
Autores principales: | Barbero, Erika M, McNally, Shawna L, Donohue, Michael C, Kagnoff, Martin F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016507/ https://www.ncbi.nlm.nih.gov/pubmed/24592899 http://dx.doi.org/10.1186/1471-230X-14-42 |
Ejemplares similares
-
Can Consumers Trust Web-Based Information About Celiac Disease? Accuracy, Comprehensiveness, Transparency, and Readability of Information on the Internet
por: McNally, Shawna L, et al.
Publicado: (2012) -
Diagnostic Value of Serologic Tests in Celiac Screening
por: Saneian, Hosein, et al.
Publicado: (2012) -
Celiac disease: Serologic prevalence in patients with irritable bowel syndrome
por: Mehdi, Zobeiri, et al.
Publicado: (2012) -
Serological screening for Celiac Disease in 382 pre-schoolers with Autism Spectrum Disorder
por: Calderoni, Sara, et al.
Publicado: (2016) -
Diagnosing Celiac Disease: Towards Wide-Scale Screening and Serology-Based Criteria?
por: Popp, Alina, et al.
Publicado: (2019)